TE

Tsukuba Exceed Fund

Description

Tsukuba Exceed Fund focus investment in deep tech startups.

Investor Profile

Tsukuba Exceed Fund has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in Japan.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Series B (100%)

Country Focus

  • Japan (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Tsukuba Exceed Fund frequently co-invest with?

Japan Lifeline
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Dai-ichi Life
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Co-Investments: 1
Alfresa Holdings
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Sony Innovation Fund
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
MAKOTO Capital
Asia, Miyagi, Japan, Sendai
Co-Investments: 1
Eight Roads Ventures
Europe, England, United Kingdom, London
Co-Investments: 1
KSP
Asia, Kanagawa, Japan, Kawasaki
Co-Investments: 1

What are some of recent deals done by Tsukuba Exceed Fund?

Metcela

Kawasaki, Kanagawa, Japan

Metcela is a clinical-stage biotech startup providing patients with an alternative treatment option for heart disease.

BiotechnologyHealth CareMedical
Series BJan 4, 2021
Amount Raised: $12,700,000